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The International Livestock Research Institute (ILRI) recently 
received funding from the European Union (Horizon 2020), 
in partnership with scientists from 19 different research 
institutes and universities around the world, to investigate 
the prevalence and the diversity of circulating BTV serotypes 
in key regions of sub-Saharan Africa. ILRI’s part of the study 
is to collect samples from different animal species present 
in different countries of Africa where BTV data is lacking. 
Emphasis will also be placed on an in-depth understanding of 
the prevalence of the virus in different agroecological zones 
in Kenya. 
Analysis of the samples will include ELISA to measure 
anti-BTV antibodies indicating prior exposure to the virus, 
quantitative PCR (qPCR) to assess the level of ongoing 
infection, and molecular typing by qPCR to identify the most 
prevalent circulating serotypes in these regions. BTV isolation 
on insect cells will also be attempted from positive field 
samples to eventually generate a biobank of BTV field isolates 
from the sub-continent. These virus strains can then be used 
for further characterization by next-generation sequencing, 
or for pathogenesis, transmission and vaccination studies at 
ILRI and with international partners.  
The data generated from this study will shed more light on 
the status of BTV in sub-Saharan African and will hopefully 
lead to strategies for a better control of the disease in the 
future. 
Key messages 
Bluetongue virus (BTV) is widespread in sub-Saharan Africa 
and causes a disease that mainly affects sheep. 
Bluetongue (BT) can cause substantial economic losses due 
to fatalities of livestock, or due to ban on the livestock trade 
between countries. 
 A better understanding of the circulating serotypes in 
Africa, spread dynamics of the virus, and the development 
of a multivalent vaccine towards BTV will allow for a better 
control and prevention of future outbreaks. 
ILRI recently received funding to investigate on the current 
circulating BTV serotypes in sub-Saharan Africa  
The disease 
Bluetongue (BT) is a vector borne disease caused by 
the bluetongue virus (BTV) that affects livestock such as 
sheep, goat or cattle. It can also infect wild animals such 
as antelopes, deer and wildebeest, to name a few. The 
disease is most severe in sheep and can result in death. 
The causative agent of this disease is an Orbivirus member 
of the Reoviridae family, a virus family in which the human 
pathogens reovirus and rotavirus are also found. Cattle are 
the principal reservoir of BTV but usually do not develop 
clinical signs of the disease.  
The clinical signs of the disease manifests within 5–10 days 
post infection and include fever; swelling of the face, lips 
and tongue; breathing difficulties; and sores on the muzzle 
and gums. Reddening will also be observed on the mucosal 
membranes of the eyes, nose and mouth. The severity of 
the disease varies depending on the viral strains, the animal 
species and the environment. 
To date, there are 27 serotypes of BTV that have been 
identified and new types are still being discovered. This virus 
is transmitted by Culicoides biting midges and is thus rightly 
called an arbovirus. However, some serotypes are transmitted 
without the help of the arthropod vector.  
The impact 
In sub-Saharan African BTV has been shown to be present 
in Ethiopia, Sudan, Kenya, Uganda, Tanzania, Botswana, 
Mozambique, Zimbabwe and South Africa. However, 
information is still lacking on BTV prevalence in other 
neighboring countries of eastern, central, and southern 
Africa. Past and recent studies have indicated the high 
level of antibodies to BTV in sentinel cattle in Western 
Kenya, reaching nearly 90% of cattle sampled being positive, 
indicating high exposure to the virus. Moreover, PCR positive 
cattle indicated that nearly 50% of them had an ongoing sub-
clinical infection. 
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Fortunately, BTV does not infect humans and therefore does 
not pose a threat to food safety. But it does pose a threat 
to food security since sheep are one of the largest livestock 
population in sub-Saharan Africa, arriving only second to 
cattle, according to the Food and Agriculture Organization of 
the United Nations (FAO). 
Understanding the dynamics behind what drives BTV spread 
can prevent new outbreaks. Several factors such as changes 
in climate can influence the spread of the virus. For example, 
rain and wind directions can significantly influence midges’ 
distribution over large territories. The high prevalence and 
diversity of the BTV serotypes circulating in sub-Saharan 
Africa poses a high risk of introducing BTV to neighboring 
regions where BTV is controlled or absent, including 
Europe. A recent BT outbreak in Europe is believed to have 
originated from a serotype only detected in sub-Saharan 
Africa.  
The only effective way to control the disease is through 
vaccination. Several vaccines are available for BTV, however, 
they are serotype specific. This poses a challenge as the 
vaccine will only protect against one serotype and will not 
provide immunity to the other circulating serotypes. Current 
research at partner institutions include developing multivalent 
vaccines that will protect against several serotypes at the 
same time.
References 
Adam, I.A., Abdalla, M.A., Mohamed, M.E. and Aradaib, I.E. 2014. Prevalence 
of bluetongue virus infection and associated risk factors among cattle 
in North Kordufan State, Western Sudan. BMC veterinary research 10. 94. 
10.1186/1746-6148-10-94. 
Belbis, G., Zientara, S., Bréard, E., Sailleau, C., Caignard, G. et al. 2017. 
Bluetongue Virus: From BTV-1 to BTV-27. Advances in Virus Research 
99:161–197. 
Bessell, P.R., Searle, K.R., Auty, H.K., Handel, I.G., Purse, B.V. and Bronsvoort, 
B.M. 2016. Assessing the potential for Bluetongue virus 8 to spread and 
vaccination strategies in Scotland. Scientific Reports 6. 38940. 10.1038/
srep38940. 
Courtejoie, N., Cauchemez, S., Zanella, G. and Durand, B. 2019. A network-
based approach to modelling bluetongue spread in France. Preventive 
Veterinary Medicine 170:104744. 
Courtejoie, N., Durand, B., Bournez, L., Gorlier, A., Bréard, E. et al. 2018. 
Circulation of bluetongue virus 8 in French cattle, before and after 
the re-emergence in 2015. Transboundary and Emerging Diseases 65(1): 
281–284. 
Elhassan, A.M., Fadol, M.A. and El Hussein, A.R. 2014. Seroprevalence of 
bluetongue virus in dairy herds with reproductive problems in Sudan. 
ISRN Veterinary Science. 2014. 595724. 10.1155/2014/595724. 
Federici, V., Goffredo, M., Mancini, G., Quaglia, M., Santilli, A. et al. 2019. Vector 
Competence of Italian Populations of Culicoides for Some Bluetongue 
Virus Strains Responsible for Recent Northern African and European 
Outbreaks. Viruses 11. 10.3390/v11100941. 
Khair, H.O., Adam, I.A., Bushara, S.B., Eltom, K.H., Musa, N.O. and Aradaib, 
I.E. 2014. Prevalence of bluetongue virus antibodies and associated risk 
factors among cattle in East Darfur State, Western Sudan. Irish Veterinary 
Journal 67(1):4. 
Mintiens, K., Méroc, E., Mellor, P.S., Staubach, C., Gerbier, G. et al. 2008. 
Possible routes of introduction of bluetongue virus serotype 8 into the 
epicentre of the 2006 epidemic in north-western Europe. Preventive 
Veterinary Medicine 87(1–2): 131–44. 
Toye, P.G., Batten, C.A., Kiara, H., Henstock, M.R., Edwards, L. et al. 2013. 
Bluetongue and epizootic haemorrhagic disease virus in local breeds of 
cattle in Kenya. Research in Veterinary Sciences 94(3):769–73.
Photo credit: ILRI/Stevie Mann
